Cytodyme
Techstars '25San Diego, US · Founded 2024 · Delaware corporation · 1 known investors
Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.
AI & Machine LearningBiotechHealthtechLegalTechMedical DevicesSaaS
Founders & leadership
Cytodyme was founded in 2024 by Tammy Ogden and Dennis White.
Investors · 1
Reported raises · per SEC filings
Form D private placements$75K disclosed across 1 round · 2026
▶$75KraisedFeb 2026 · 3 investors · OtherRule 506(b)
▶$75KraisedFeb 2026 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tammy OgdenExecutive Officer, Director
- Stephen Brown-BourneExecutive Officer, Director
- Dennis WhiteExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $75K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapKite Pharma3 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.
CytomX3 shared keywordsCytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue. It advances a pipeline of Probody therapeutics through preclinical research and clinical trials in oncology.
Companies competing with Cytodyme for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cytodyme do?
- Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.
- Who founded Cytodyme?
- Cytodyme was founded by Tammy Ogden, Dennis White in 2024.
- Who are Cytodyme's investors?
- Cytodyme's investors include Techstars.
- How much funding has Cytodyme raised?
- Cytodyme has disclosed $75K raised across 1 round.
- Where is Cytodyme headquartered?
- Cytodyme is headquartered in San Diego, US.